Resultados de la búsqueda 121-130 of 410 for Snake envenoming

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to combine MRI images with histologic and genetic analysis of cancer (from blood and tissue samples) to improve the overall ...

  2. Nefrología e hipertensión - Ensayos clínicos

    Infórmate sobre los ensayos clínicos que se llevan a cabo en Mayo Clinic para mejorar el diagnóstico, la atención médica y los resultados para las personas ...

  3. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to combine MRI images with histologic and genetic analysis of cancer (from blood and tissue samples) to improve the overall ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to determine whether there is an increase in the time of a first occurrence of either: local recurrence, leptomeningeal disease ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...

  6. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to assess the 36-month incidence of pelvic/non-vaginal recurrence among patients with surgical stage I intermediate-risk ...

  7. Oncología (médica) - Ensayos clínicos

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The goal of this protocol is to collect biospecimens in order to prospectively evaluate diagnostic and prognostic performance of MDMs for detection of advanced ...

  9. Oncología (médica) - Ensayos clínicos

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...